International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet1997; 349, 1569–81.
2.
BarnettHJMKasteMMeldrumHEliasziwM. Aspirin dose in stroke prevention. Beautiful hypotheses slain by ugly facts. Stroke, 1996; 27, 588–92.
3.
DienerHCunhaLForbesCSiveniusJSmetsPLowenthalA. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke, J Neurol Sciences1996; 143, 1–13.
4.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet1996; 348, 1329–39.
5.
European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet1993; 342: 1255–62.
6.
MooreWSBarnettHJBeebeHG. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke, 1995; 26: 188–201.
7.
Management of patients with stroke I: Assessment, investigation, immediate management and secondary prevention. A national clinical guideline recommended for use in Scotland by the Scottish Intercollegiate Guidelines Network No 13, 1977; SIGN, RCPE, Edinburgh.
8.
SpracklingMEMitchellJRShortAHWattG. Blood pressure reduction in the elderly: A randomised controlled trial of methyldopa. Br Med J, 1981; 283, 1151–53.
9.
BlauwGJLagaayAMSmeltAHMWestendorpRGJ. Stroke, Statins, and Cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke, 1997; 28, 946–50.
HerbertPRGazianoMChanKSHennekensCH. Cholesterol lowering with statin drugs, risk of stroke and total mortality — An overview of randomized trials. JAMA, 1997; 278: 313–321.
